Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly Other Working Capital Changes of -$1.0 million for Q1 2026, down 282.13% year-over-year from $551805.8 in Q1 2025, and down 189.49% quarter-over-quarter from $1.1 million in Q4 2025.
Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Other Working Capital Changes for 6 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 282.13% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$2.1 million (down 0.92% YoY), while the FY2025 annual figure was -$1.3 million, up 46.1% from the prior year.
- Other Working Capital Changes slipped to -$1.0 million in Q1 2026 per CRBU's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q3 2024 and bottomed at -$1.9 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$61941.2 across 5 years, with a median of -$62000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 704.12% in 2023 and fell as far as 1190.59% in 2023.
- Caribou Biosciences' Other Working Capital Changes stood at $2.9 million in 2022, then sank by 121.09% to -$606000.0 in 2023, then tumbled by 235.97% to -$2.0 million in 2024, then jumped by 155.16% to $1.1 million in 2025, then sank by 189.49% to -$1.0 million in 2026.
- Business Quant data shows CRBU's Other Working Capital Changes at -$1.0 million in Q1 2026, $1.1 million in Q4 2025, and -$627000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Caribou Biosciences | 163.09 Mn | 50.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -52,000.00 |
| Jun 30, 2026 | -52,000.00 |
| Jun 30, 2026 | -52,000.00 |
| Mar 31, 2026 | -522,000.00 |
| Mar 31, 2026 | -522,000.00 |
| Mar 31, 2026 | -522,000.00 |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | -930,000.00 |
| Sep 30, 2025 | -930,000.00 |
| Sep 30, 2025 | -930,000.00 |
| Jun 30, 2025 | -340,000.00 |
| Jun 30, 2025 | -340,000.00 |
| Jun 30, 2025 | -340,000.00 |
| Mar 31, 2025 | -471,000.00 |
| Mar 31, 2025 | -471,000.00 |
| Mar 31, 2025 | -471,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2024 | 780,000.00 |